Drug-eluting stents in preclinical studies: recommended evaluation from a consensus group.
D000792:Angiography / Q000592:standards; D000818:Animals; D018929:Cell Culture Techniques; D020099:Coated Materials, Biocompatible / Q000592:standards; D003245:Consensus Statements as Topic; D003324:Coronary Artery Disease / Q000473:pathology / Q000628:therapy; D003692:Delayed-Action Preparations / Q000009:adverse effects / Q000493:pharmacokinetics / Q000592:standards; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical / Q000592:standards*; D004343:Drug Implants / Q000009:adverse effects / Q000493:pharmacokinetics / Q000592:standards; D006083:Graft Occlusion, Vascular / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D007083:Iliac Artery; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011817:Rabbits; D012107:Research Design / Q000592:standards*; D015607:Stents / Q000009:adverse effects / Q000145:classification / Q000592:standards; D013552:Swine; D013927:Thrombosis / Q000517:prevention & control; D016707:Tissue Fixation
D020099:Coated Materials, Biocompatible; D003692:Delayed-Action Preparations; D004343:Drug Implants; D010975:Platelet Aggregation Inhibitors